RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3058% above fair value
$74.92−1.97 (-2.56%)
Close on Nov 17, 2026Market cap $5.90BP/E –Yield –
RadNet operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
RadNet's operating income for the twelve months ending Jun 30, 2026 was $70.78M, up 8.5% year over year. For fiscal 2025 it was $61.99M, down 40.7% from the year before. Over ten years it grew 4.7% a year on average. The highest annual figure on record is $104.62M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.99M | -40.7% |
| FY2024 | Dec 31, 2024 | $104.62M | +6.0% |
| FY2023 | Dec 31, 2023 | $98.70M | +112.9% |
| FY2022 | Dec 31, 2022 | $46.36M | -43.8% |
| FY2021 | Dec 31, 2021 | $82.55M | +131.3% |
| FY2020 | Dec 31, 2020 | $35.68M | -48.9% |
| FY2019 | Dec 31, 2019 | $69.88M | +126.2% |
| FY2018 | Dec 31, 2018 | $30.89M | -38.3% |
| FY2017 | Dec 31, 2017 | $50.05M | +30.1% |
| FY2016 | Dec 31, 2016 | $38.48M | -1.6% |
| FY2015 | Dec 31, 2015 | $39.12M | +264.8% |
| FY2014 | Dec 31, 2014 | $10.72M | -7.8% |
| FY2013 | Dec 31, 2013 | $11.63M | -8.0% |
| FY2012 | Dec 31, 2012 | $12.64M | +50.6% |
| FY2011 | Dec 31, 2011 | $8.39M | -7.7% |
| FY2010 | Dec 31, 2010 | $9.09M | -78.4% |
| FY2009 | Dec 31, 2009 | $42.10M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $39.47M | +27.8% |
| Q1 FY2026 | Mar 31, 2026 | -$23.90M | – |
| Q4 FY2025 | Dec 31, 2025 | $27.83M | +13.5% |
| Q3 FY2025 | Sep 30, 2025 | $27.39M | -19.2% |
| Q2 FY2025 | Jun 30, 2025 | $30.88M | -11.4% |
| Q1 FY2025 | Mar 31, 2025 | -$24.10M | -312.5% |
| Q4 FY2024 | Dec 31, 2024 | $24.53M | +0.8% |
| Q3 FY2024 | Sep 30, 2024 | $33.91M | -21.6% |
| Q2 FY2024 | Jun 30, 2024 | $34.85M | +42.6% |
| Q1 FY2024 | Mar 31, 2024 | $11.34M | +70.0% |
| Q4 FY2023 | Dec 31, 2023 | $24.33M | +12.6% |
| Q3 FY2023 | Sep 30, 2023 | $43.25M | +524.7% |
| Q2 FY2023 | Jun 30, 2023 | $24.44M | +25.0% |
| Q1 FY2023 | Mar 31, 2023 | $6.67M | – |
| Q4 FY2022 | Dec 31, 2022 | $21.60M | +364.4% |
| Q3 FY2022 | Sep 30, 2022 | $6.92M | -78.7% |
| Q2 FY2022 | Jun 30, 2022 | $19.56M | -29.3% |
| Q1 FY2022 | Mar 31, 2022 | -$1.72M | -109.7% |
| Q4 FY2021 | Dec 31, 2021 | $4.65M | -77.7% |
| Q3 FY2021 | Sep 30, 2021 | $32.57M | +39.3% |
| Q2 FY2021 | Jun 30, 2021 | $27.68M | +15362.6% |
| Q1 FY2021 | Mar 31, 2021 | $17.65M | – |
| Q4 FY2020 | Dec 31, 2020 | $20.90M | -12.1% |
| Q3 FY2020 | Sep 30, 2020 | $23.38M | +38.7% |
| Q2 FY2020 | Jun 30, 2020 | $179.00K | -99.2% |
| Q1 FY2020 | Mar 31, 2020 | -$8.78M | -220.7% |
| Q4 FY2019 | Dec 31, 2019 | $23.77M | – |
| Q3 FY2019 | Sep 30, 2019 | $16.85M | +2.4% |
| Q2 FY2019 | Jun 30, 2019 | $21.98M | +38.5% |
| Q1 FY2019 | Mar 31, 2019 | $7.27M | – |
| Q4 FY2018 | Dec 31, 2018 | -$544.00K | -103.0% |
| Q3 FY2018 | Sep 30, 2018 | $16.45M | +51.7% |
| Q2 FY2018 | Jun 30, 2018 | $15.87M | +12.1% |
| Q1 FY2018 | Mar 31, 2018 | -$888.00K | -113.2% |
| Q4 FY2017 | Dec 31, 2017 | $18.30M | +22.3% |
| Q3 FY2017 | Sep 30, 2017 | $10.84M | -12.9% |
| Q2 FY2017 | Jun 30, 2017 | $14.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.75M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.97M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.45M | – |
See a number that looks wrong?